| Primary |
| Chronic Obstructive Pulmonary Disease |
73.1% |
| Hypertension |
4.9% |
| Emphysema |
3.2% |
| Asthma |
2.7% |
| Bronchitis Chronic |
2.4% |
| Diabetes Mellitus |
2.0% |
| Atrial Fibrillation |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Depression |
1.1% |
| Bronchitis |
1.0% |
| Hypothyroidism |
0.9% |
| Anxiety |
0.6% |
| Benign Prostatic Hyperplasia |
0.6% |
| Insomnia |
0.6% |
| Lung Disorder |
0.6% |
| Oedema Peripheral |
0.6% |
| Pain |
0.6% |
| Supplementation Therapy |
0.6% |
| Blood Glucose Increased |
0.4% |
|
| Weight Decreased |
18.7% |
| Diarrhoea |
11.6% |
| Nausea |
9.1% |
| Suicidal Ideation |
8.3% |
| Insomnia |
7.8% |
| Tremor |
6.6% |
| Death |
4.0% |
| Dyspnoea |
3.8% |
| Off Label Use |
3.8% |
| Dizziness |
3.5% |
| Chronic Obstructive Pulmonary Disease |
3.3% |
| Headache |
3.0% |
| Vomiting |
2.8% |
| Atrial Fibrillation |
2.3% |
| Back Pain |
2.0% |
| Pain In Extremity |
2.0% |
| Rash |
2.0% |
| Abdominal Pain |
1.8% |
| Anxiety |
1.8% |
| Nervousness |
1.8% |
|
| Secondary |
| Chronic Obstructive Pulmonary Disease |
41.7% |
| Product Used For Unknown Indication |
17.0% |
| Hypertension |
7.1% |
| Asthma |
6.3% |
| Bronchitis Chronic |
5.7% |
| Emphysema |
4.8% |
| Bronchitis |
2.1% |
| Anxiety |
1.8% |
| Blood Cholesterol Increased |
1.8% |
| Cough |
1.5% |
| Diabetes Mellitus |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Pain |
1.2% |
| Aspergillosis |
0.9% |
| Cerebrovascular Accident |
0.9% |
| Depression |
0.9% |
| Hypothyroidism |
0.9% |
| Ill-defined Disorder |
0.9% |
| Multiple Allergies |
0.9% |
| Nephrolithiasis |
0.9% |
|
| Weight Decreased |
20.0% |
| Tremor |
14.5% |
| Pneumonia |
10.9% |
| Swelling Face |
7.3% |
| Convulsion |
5.5% |
| Ventricular Tachycardia |
5.5% |
| Diarrhoea |
3.6% |
| Dizziness |
3.6% |
| Headache |
3.6% |
| Irritability |
3.6% |
| Mania |
3.6% |
| Suicidal Ideation |
3.6% |
| Abdominal Pain |
1.8% |
| Adverse Drug Reaction |
1.8% |
| Ageusia |
1.8% |
| Angioedema |
1.8% |
| Arthralgia |
1.8% |
| Back Pain |
1.8% |
| Blood Glucose Increased |
1.8% |
| Bronchitis |
1.8% |
|
| Concomitant |
| Chronic Obstructive Pulmonary Disease |
27.2% |
| Product Used For Unknown Indication |
17.7% |
| Asthma |
10.6% |
| Emphysema |
9.8% |
| Hypertension |
4.5% |
| Pain |
3.6% |
| Drug Use For Unknown Indication |
3.0% |
| Blood Cholesterol Increased |
2.5% |
| Diabetes Mellitus |
2.5% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Rheumatoid Arthritis |
2.3% |
| Cardiac Disorder |
2.1% |
| Depression |
2.1% |
| Dyspnoea |
2.1% |
| Supplementation Therapy |
1.7% |
| Anxiety |
1.5% |
| Alpha-1 Anti-trypsin Deficiency |
1.3% |
| Atrial Fibrillation |
1.1% |
| Hepatitis C |
1.1% |
| Chest Pain |
0.9% |
|
| Dyspnoea |
10.7% |
| Pneumonia |
10.7% |
| Wheezing |
8.9% |
| Product Quality Issue |
7.1% |
| Death |
5.4% |
| Drug Ineffective |
5.4% |
| Macular Degeneration |
5.4% |
| Weight Decreased |
5.4% |
| Weight Increased |
5.4% |
| Chronic Obstructive Pulmonary Disease |
3.6% |
| Dizziness |
3.6% |
| Needle Issue |
3.6% |
| Off Label Use |
3.6% |
| Pain |
3.6% |
| Respiratory Distress |
3.6% |
| Swelling |
3.6% |
| Upper Respiratory Tract Infection |
3.6% |
| Urticaria |
3.6% |
| Abnormal Dreams |
1.8% |
| Adverse Event |
1.8% |
|
| Interacting |
| Chronic Obstructive Pulmonary Disease |
43.1% |
| Emphysema |
33.8% |
| Smoking Cessation Therapy |
6.2% |
| Rheumatoid Arthritis |
4.6% |
| Diabetes Mellitus |
3.1% |
| Hypertension |
3.1% |
| Benign Prostatic Hyperplasia |
1.5% |
| Blood Cholesterol Increased |
1.5% |
| Gout |
1.5% |
| Heart Rate Irregular |
1.5% |
|
| Tachycardia |
28.6% |
| Tremor |
28.6% |
| Drug Interaction |
14.3% |
| Prothrombin Time Prolonged |
14.3% |
| Rheumatoid Arthritis |
14.3% |
|
